Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/14/2012EP2521784A2 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/14/2012EP2521782A1 Flt3 receptor antagonists for the treatment or the prevention of pain disorders
11/14/2012EP2521738A1 Cosmetic or dermatological composition, cosmetic treatment method, and hyaluronic acid derivative
11/14/2012EP2521732A2 Serine hydrolase formulation
11/14/2012EP2521731A1 Compounds with both analgesic and anti-hyperalgesic efficacy
11/14/2012EP2521727A1 Novel benzoic pyrrolopyridine derivatives
11/14/2012EP2521726A1 5-oxo-5, 8-dihydropyrido [2, 3-d]pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases
11/14/2012EP2521725A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
11/14/2012EP2521724A2 Agents and methods for treating ischemic and other diseases
11/14/2012EP2521721A1 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
11/14/2012EP2521719A1 Fumagillol type compounds and methods of making and using same
11/14/2012EP2521716A2 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof
11/14/2012EP2521715A1 Piperazines as antimalarial agents
11/14/2012EP2521714A1 Sulfone compounds as 5-ht6 receptor ligands
11/14/2012EP2521713A2 Dp2 antagonist and uses thereof
11/14/2012EP2521711A1 Quaternary ammonium salt prodrugs
11/14/2012EP2521707A1 Bisphenol derivatives and their use as androgen receptor activity modulators
11/14/2012EP2521594A2 Obesity small molecules
11/14/2012EP2521570A2 Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
11/14/2012EP2521569A1 Combined treatment utilizing vb-201
11/14/2012EP2521560A1 Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atherosclerosis and cardiovascular disease
11/14/2012EP2521559A1 Nutritive compositions and methods of using same
11/14/2012EP2521558A1 Topical lightening composition and uses thereof
11/14/2012EP2521557A1 Anti-heparin compounds
11/14/2012EP2521556A2 Modulation of angiopoietin-like 3 expression
11/14/2012EP2521555A1 Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors
11/14/2012EP2521554A2 Materials and methods for prevention and treatment of viral infections
11/14/2012EP2521553A2 Methods and compositions of targeted drug development
11/14/2012EP2521552A1 Diazoxide for use in the treatment of a central nervous system (cns) autoimmune demyelinating disease
11/14/2012EP2521551A2 Methods and compositions of targeted drug development
11/14/2012EP2521550A1 Treatment method
11/14/2012EP2521549A1 Therapeutic compounds and related methods of use
11/14/2012EP2521548A2 Quinazolin-4(3a)-one derivatives and methods of use thereof
11/14/2012EP2521547A2 Methods and compositions for applying moxifloxacin to the ear
11/14/2012EP2521546A2 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
11/14/2012EP2521545A1 Prodrugs of heteraromatic compounds
11/14/2012EP2521544A2 Topical transdermal dexmedetomidine compositions and methods of use thereof
11/14/2012EP2521543A1 A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer
11/14/2012EP2521542A1 D- amino acids for use in treating biofilms
11/14/2012EP2521541A2 Prophylaxis of skin cancer with retinamides
11/14/2012EP2521540A2 Solid oral dosage form containing olmesartan medoxomil
11/14/2012EP2521539A2 Injectable formulations for parenteral administration
11/14/2012EP2521536A2 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
11/14/2012EP2521528A2 Use of at least one extract of flowers of camellia japonica alba plena for moisturizing the skin
11/14/2012EP2521454A1 Treatment with vb-201
11/14/2012EP2521453A1 Methods and compositions for the treatment of migraine headaches
11/14/2012EP2521451A1 Hedgehog inhibitors
11/14/2012EP2521449A1 Nutritive compositions and methods of using same
11/14/2012EP2521447A1 Fatty acid fumarate derivatives and their uses
11/14/2012EP2521446A2 Fatty acid derivatives and analogs of drugs
11/14/2012CN1675250B Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
11/14/2012CN1668721B Immunoadhesin comprising a glycoprotein VI domain
11/14/2012CN1568958B Unsaturated fatty acid formula products with high content of alpha and gamma linolenic acid and preparation method threreof
11/14/2012CN1434795B Acyl pseudodipeptides which carry a functionalised auxiliary arm
11/14/2012CN102782155A Compositions and methods for microrna expession profiling in plasma of lung cancer
11/14/2012CN102782139A Novel therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors
11/14/2012CN102782135A Treatment of RNase H1 related diseases by inhibition of natural antisense transcript to RNase H1
11/14/2012CN102782134A Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1
11/14/2012CN102782133A SiRNA for inhibiting c-Met expression and an anti-cancer composition comprising the same
11/14/2012CN102781943A Benzodiazepine bromodomain inhibitor
11/14/2012CN102781942A Disubstituted octahy-dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
11/14/2012CN102781941A Bridgehead amine ring-fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders
11/14/2012CN102781940A Substituted imidazopyridinyl-aminopyridine compounds
11/14/2012CN102781939A Palonosetron metabolites
11/14/2012CN102781937A Bis(difluormethyl)pyrazoles used as fungicides
11/14/2012CN102781936A Heterocyclic compound having azole group
11/14/2012CN102781935A Extracts from kibdelos porangium as antibacterial agents
11/14/2012CN102781933A Substituted benzoazepines as toll-like receptor modulators
11/14/2012CN102781931A 5-alkynyl pyrimidines and their use as kinase inhibitors
11/14/2012CN102781930A Novel anti-platelet agent
11/14/2012CN102781929A Nicotine haptens, immunoconjugates and their uses
11/14/2012CN102781924A Selenalzole derivative having ligand which activates Peroxisome Proliferator Activated Receptor (PPAR), preparing method thereof and usage of the chemical compounds
11/14/2012CN102781923A 5-alkynyl-pyrimidines
11/14/2012CN102781922A TGR5 agonists
11/14/2012CN102781919A Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
11/14/2012CN102781916A Compounds as bradykinin B1 antagonists
11/14/2012CN102781914A Indole derivative
11/14/2012CN102781910A Alkylamine derivative
11/14/2012CN102781517A Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus
11/14/2012CN102781480A Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
11/14/2012CN102781473A Pharmaceutical composition for external use
11/14/2012CN102781453A The use of LPA for encouraging pregnancy, and fertility agent
11/14/2012CN102781452A Method of reducing incidence of intraocular pressure associated with intraocular use of corticosteroids
11/14/2012CN102781451A Compositions and methods for treating bacterial infections using ceftaroline
11/14/2012CN102781450A Treatment method
11/14/2012CN102781449A Methods for enhancing natural killer cell proliferation and activity
11/14/2012CN102781448A Compositions and methods for treating viral diseases
11/14/2012CN102781447A Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
11/14/2012CN102781446A Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
11/14/2012CN102781445A Sigma ligands for use in the prevention and/or treatment of postoperative pain
11/14/2012CN102781444A Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma
11/14/2012CN102781443A Apremilast For The Treatment Of Sarcoidosis
11/14/2012CN102781442A Method of treating scars and beta-catenin-mediated disorders using nefopam compounds
11/14/2012CN102781441A Salts, solvates, and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same
11/14/2012CN102781439A Oral care compositions and methods
11/14/2012CN102781438A Anaplerotic therapy for alzheimer's disease and the aging brain
11/14/2012CN102781437A Use of agomelatine for the preparation of drugs for treating obsessive compulsive disorder (OCD)
11/14/2012CN102781436A Methods for treating fibromyalgia syndrome
11/14/2012CN102781435A Combination of carotenoids and epi-lutein
11/14/2012CN102781434A Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
1 ... 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 ... 7860